Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272868 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbial Transplant in Pediatric Crohn's Disease
A Phase 1 study, sponsored by Seattle Children's Hospital.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02272868 is a Phase 1 study that was terminated before completion, run by Seattle Children's Hospital. The registered enrollment target is 7 participants.
The verdict
NCT02272868, a Phase 1 study, was terminated before completion, sponsored by Seattle Children's Hospital.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
Interventions
- DRUG Normal Saline
- BIOLOGICAL Fecal Microbial transplant
- DRUG rifaximin+omeprazole+miralax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-10-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272868
The ClinicalTrials.gov registry entry for NCT02272868 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT02272868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02272868 about?
NCT02272868 is a clinical study titled "Fecal Microbial Transplant in Pediatric Crohn's Disease". This is a double blind placebo control trial of fecal microbial transplantation for active Crohn's disease in patients 12 to 21 years of age.
What is the current status of trial NCT02272868?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2015-01. Estimated completion is 2016-10-01.
What interventions are being tested in trial NCT02272868?
The interventions under investigation include: Normal Saline (DRUG), Fecal Microbial transplant (BIOLOGICAL), rifaximin+omeprazole+miralax (DRUG).
Who is sponsoring clinical trial NCT02272868?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.